The Louise And Alan Edwards Foundation Report issue

Foundation Phase 2

Organization Overview

First Clinical Trial
2016
NCT02984397
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

The Louise And Alan Edwards Foundation